This study quantified the health and economic impacts of endocrine-disrupting chemical (EDC) exposure in the U.S., estimating annual costs exceeding $340 billion, or over 2.3% of GDP. Utilizing epidemiological and toxicological models, the research identified significant associations between EDCs and various health outcomes. Key findings include: Polybrominated diphenyl ethers (PBDEs)
